Email This Article

Headlines & Perspectives
FDA Delays Approval of Amag's Ferumoxytol
By Adam Feuerstein
12/23/08 - 03:51 AM EST
Unresolved manufacturing issues have contributed to a delay in the approval of Amag Pharmaceuticals' injectable iron replacement therapy.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,233.29 1,091.43 2,157.85 34.77
Oil *
76.06
DOWN
57.97
DOWN
7.08
DOWN
9.05
UP
0.03
10 Yr
3.48%
SPDR Gold
108.63
-0.56%
-0.64%
-0.42%
+0.09%
Data delayed 20 minutes

Brokerage Partners